(3R,8S,8aR)-2-methyl-1,4-dioxohexahydro-1H-3,8a-epidithiopyrrolo[1,2-a]pyrazin-8-yl acetate | 1001166-80-8

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: (3R,8S,8aR)-2-methyl-1,4-dioxohexahydro-1H-3,8a-epidithiopyrrolo[1,2-a]pyrazin-8-yl acetate
• 英文别名: [(1R,2S,7R)-11-methyl-6,10-dioxo-8,9-dithia-5,11-diazatricyclo[5.2.2.01,5]undecan-2-yl] acetate
• CAS: 1001166-80-8
• 化学式: C₁₀H₁₂N₂O₄S₂
• 分子量: 288.348
• InChiKey: MMAVBFBMVANDEX-SKWCMTHISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  118
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (3R,8S,8aR)-2-methyl-1,4-dioxohexahydro-1H-3,8a-epidithiopyrrolo[1,2-a]pyrazin-8-yl acetate 在 scandium tris(trifluoromethanesulfonate) 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 7.0h， 以100%的产率得到(3R,8S,8aR)-8-hydroxy-2-methyltetrahydro-1H-3,8a-epidithiopyrrolo[1,2-a]pyrazine-1,4(6H)-dione
  参考文献：
  名称：

  Construction of Epidithiodioxopiperazines by Directed Oxidation of Hydroxyproline-Derived Dioxopiperazines

  摘要：

  Functionalization of the angular methine carbon of hydroxyproline-derived dioxopiperazines by a radical-promoted C-H bond oxidation, which is directed by a proximal (bromomethyl)silyl group, is described. This regioselective oxidation is the key step in a new synthesis of epidithiodioxopiperazines.

  DOI：

  10.1021/ol702518t
• 作为产物：
  描述：

  在 氧气 作用下， 以 甲醇 为溶剂， 反应 12.0h， 以16.5 mg的产率得到(3R,8S,8aR)-2-methyl-1,4-dioxohexahydro-1H-3,8a-epidithiopyrrolo[1,2-a]pyrazin-8-yl acetate
  参考文献：
  名称：

  Construction of Epidithiodioxopiperazines by Directed Oxidation of Hydroxyproline-Derived Dioxopiperazines

  摘要：

  Functionalization of the angular methine carbon of hydroxyproline-derived dioxopiperazines by a radical-promoted C-H bond oxidation, which is directed by a proximal (bromomethyl)silyl group, is described. This regioselective oxidation is the key step in a new synthesis of epidithiodioxopiperazines.

  DOI：

  10.1021/ol702518t

文献信息

• [EN] T-CELL LYMPHOMA TREATMENTS<br/>[FR] TRAITEMENTS DE LYMPHOME T
  申请人：HOPE CITY

  公开号：WO2018232274A1

  公开（公告）日：2018-12-20

  Described herein are methods for treating T-cell lymphoma in a subject in need thereof, comprising administering to the subject in need thereof, an ETP compound. Also described herein are pharmaceutical compositions and compositions for use that include such ETP compound.

  本文描述了治疗需要的T细胞淋巴瘤的方法，包括向需要的受试者施用ETP化合物。本文还描述了包含这种ETP化合物的药物组合物和用途组合物。
• [EN] ETP DERIVATIVES<br/>[FR] DÉRIVÉS D'ÉTOPOSIDE
  申请人：HOPE CITY

  公开号：WO2014066435A1

  公开（公告）日：2014-05-01

  Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.

  本文提供了ETP衍生物的合成。此处描述的ETP衍生物的用途包括治疗癌症。
• ETP derivatives
  申请人：City of Hope

  公开号：US10246471B2

  公开（公告）日：2019-04-02

  Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.

  本文特别提供了 ETP 衍生物的合成方法。本文所述 ETP 衍生物的用途包括治疗癌症。
• Synthesis of ETP derivatives
  申请人：CITY OF HOPE

  公开号：US11230560B2

  公开（公告）日：2022-01-25

  Provided herein, inter alia, is the synthesis of ETP derivatives. The synthetic methods described herein include converting a ring bridging trisulfide compound of formula to a ring bridging disulfide compound of formula Also provided herein are compositions comprising thereof.

  本文特别提供了 ETP 衍生物的合成方法。本文所述的合成方法包括将环桥三硫化物化合物转化为式 转化为式 本文还提供了由其组成的组合物。
• EP2909214A1
  申请人：——

  公开号：EP2909214A1

  公开（公告）日：2015-08-26